Navigation Links
Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)
Date:7/17/2009

Vectibix is indicated as a single agent for the treatment of patients with epidermal growth factor receptor (EGFr)- expressing metastatic colorectal carcinoma after disease progression on, or following fluoropyrimidine-, oxaliplatin- and irinotecan-containing chemotherapy regimens. The effectiveness of Vectibix as a single agent for the treatment of EGFr-expressing, metastatic colorectal carcinoma is based on progression-free survival. Currently no data demonstrate an improvement in disease-related symptoms or increased survival with Vectibix.

Important Product Safety Information

Dermatologic Toxicity: Dermatologic toxicities occurred in 89 percent of patients and were severe (NCI-CTC grade 3 and higher) in 12 percent of patients receiving Vectibix monotherapy. Withhold Vectibix for dermatologic toxicities that are grade 3 or higher or are considered intolerable. If toxicity does not improve to less than or equal to grade 2 within 1 month, permanently discontinue Vectibix. The clinical manifestations included, but were not limited to, dermatitis acneiform, pruritus, erythema, rash, skin exfoliation, paronychia, dry skin, and skin fissures. Subsequent to the development of severe dermatologic toxicities, infectious complications, including sepsis, septic death, and abscesses requiring incisions and drainage were reported.

Infusion Reactions: Severe infusion reactions occurred in approximately 1 percent of patients. Severe infusion reactions included anaphylactic reactions, bronchospasm, and hypotension. Although not reported with Vectibix, fatal infusion reactions have occurred with other monoclonal antibody products. Stop infusion if a severe infusion reaction occurs. Depending on the severity and/or persistence of the reaction, permanently discontinue Vectibix.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotech
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Amgen Appoints Rebecca M. Henderson to the Companys Board of Directors
2. 34 Outstanding Teachers and Schools Receive $10,000 Amgen Award for Science Teaching Excellence
3. AUDIO from Medialink and Amgen: Experts Agree Infection in Cancer Patients Impacts Treatment Success
4. Amgen to Present at the Goldman Sachs Global Healthcare Conference
5. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
6. Amgens Denosumab and Eli Lillys Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018
7. Amgen Highlights Data to Be Presented at ASCO
8. Amgen to Present at the Deutsche Bank 34th Annual Healthcare Conference
9. Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
10. Amgens First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
11. Amgen Announces Webcast of 2009 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... (PRWEB) July 22, 2014 Air Conditioning ... are now an authorized Daikin comfort pro dealer. This ... Daikin indoor heating and cooling system equipment. Only a ... is thoroughly reviewed before being approved. , Daikin co-developed ... in the Split System Air Conditioning Market. They are ...
(Date:7/22/2014)... The 2014 Warrior-Family Symposium (WFS) ... Building and International Trade Center in Washington, D.C. ... Civilian Communities,” will be held from 8:30 a.m. ... and cohosted by the Military Officers Association of ... (NDIA). USAA is the Executive Sponsor of the ...
(Date:7/22/2014)... York, NY (PRWEB) July 22, 2014 ... http://www.xareltolawsuitcenter.com/ ) that alleges the death of ... caused by the blood thinner, Bernstein Liebhard LLP reports. ... U.S. District Court for the Southern District of ... in January 2012, and suffered a subdural hemorrhage the ...
(Date:7/22/2014)... American Society of Hematology (ASH) will honor Tomas Ganz, ... Angeles with the 2014 E. Donnall Thomas Lecture for ... of the iron-regulatory hormone hepcidin and investigation of its ... Nobel Prize Laureate and past Society president E. Donnall ... have represented a paradigm shift or significant discovery in ...
(Date:7/22/2014)... of the Clean Plate Club you eat pretty much ... A new Cornell University study shows that the average ... his or her plate. "If you put it ... Wansink Ph.D., author of the forthcoming book, Slim by Design, ... Brand Lab. , Wansink and co-author Katherine Abowd Johnson analyzed ...
Breaking Medicine News(10 mins):Health News:Air Conditioning & Heating Inc. Now an Authorized Daikin Comfort Pro Dealer 2Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 2Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 3Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 3Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3
... tension, ... avoid tissue damage, ANDOVER, Mass., Sept. 26 Smith ... launch of the,KINSA RC 5.5 Suture Anchor, designed to provide secure repair ... of muscles,and tendons that control shoulder motion. Surgeons can repair these ...
... a Federal Register,notice,( http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=FEDERAL_REGI ,STER&p_id=19934) published ... (OSHA) is inviting the public to ... Occupational Exposure to Diacetyl and Food,Flavorings ... provide another opportunity for the agency ...
... - September 26, 2007 Research from La ... endoscopy diagnoses more Crohns disease recurrence after surgery than ... more than half of the patients studied. The ... the monthly peer-reviewed scientific journal of the American Society ...
... GlaxoSmithKline Team Unveil Unique Initiative at ADA,s Annual,Meeting Here, ... oral health and overall health, including heart,problems, diabetes and ... maintain good dental health for a lifetime., According ... Control and,Prevention, more adults are keeping their natural teeth ...
... Barriers around informed consent are impeding lifesaving research, experts ... experts have released new recommendations designed to increase the ... are likely to die without treatment. , U.S. law ... risk and agree to participate before they,re enrolled in ...
... as important for the mind as it is for the ... possibility that Alzheimers memory loss could be due to a ... University have discovered why brain insulin signaling -- crucial for ... have shown that a toxic protein found in the brains ...
Cached Medicine News:Health News:Smith & Nephew Endoscopy's KINSA(R) RC Suture Anchor Designed for Secure Repair of Rotator Cuff Injuries 2Health News:Smith & Nephew Endoscopy's KINSA(R) RC Suture Anchor Designed for Secure Repair of Rotator Cuff Injuries 3Health News:Smith & Nephew Endoscopy's KINSA(R) RC Suture Anchor Designed for Secure Repair of Rotator Cuff Injuries 4Health News:OSHA Seeks Input from Stakeholders on Diacetyl and Food Flavorings Containing Diacetyl 2Health News:Capsule endoscopy diagnoses more Crohn's disease recurrence after surgery than colonoscopy 2Health News:Capsule endoscopy diagnoses more Crohn's disease recurrence after surgery than colonoscopy 3Health News:OralLongevity (TM) Program Targets Oral Health of Older Americans 2Health News:OralLongevity (TM) Program Targets Oral Health of Older Americans 3Health News:Guidelines Seek to Boost Study of Critically Ill 2Health News:Discovery supports theory of Alzheimer's disease as form of diabetes 2Health News:Discovery supports theory of Alzheimer's disease as form of diabetes 3
(Date:7/22/2014)... 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... the development and commercialization of a once-daily, oral therapy ... announced today that the U.S. Food and Drug Administration, ... IND, application.  Such clearance will permit Galmed to conduct ... the United States for the treatment ...
(Date:7/22/2014)... /PRNewswire-iReach/ -- Reproductive Medicine Associates of New York ... a nationally and internationally-recognized leader in providing exceptional quality ... pleased to announce a new collaboration with EMD Serono ... recognize the sacrifices made by veterans and their families ... will allow qualifying veterans and the spouses of veterans ...
(Date:7/22/2014)... July 22, 2014  ConvaTec, a privately-held medical products ... has been appointed chief financial officer of the ... was previously executive vice president and chief financial officer ... biotechnology company.  Mr. Clerkin was part of a senior ... culminating in its sale to Perrigo, a pharmaceutical manufacturer, ...
Breaking Medicine Technology:Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 2Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 3Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 4Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 2Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 3ConvaTec Names Nigel Clerkin Chief Financial Officer 2
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
... SkanWasher 400 is an ... washer with built-in pressure ... individual pressure settings allow ... gentle wash to a ...
Lab-Reader...
Fully automatic NRTL and CE certified microplate reader....
Medicine Products: